Prof. Amelie Karlström, KTH Royal Institute of Technology, Stockholm, Sweden

Radionuclide Therapy Using Peptide Cucleic Acid (PNA)-Mediated Pretargeting of HER2-Expressing Tumors

Start Date 13.02.2020 - 16:30
Event End 13.02.2020 - 17:30
Location Université de Genève

Radionuclide Therapy Using Peptide Cucleic Acid (PNA)-Mediated Pretargeting of HER2-Expressing Tumors